BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants

Azzeme Harun1, Richard Muhammad Johari James, Siong Meng Lim

  • 1Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.

Abstract

Insights

Endophytic fungal extracts show promise in inhibiting Beta-secretase 1 (BACE1), an enzyme linked to Alzheimer's disease. Further research is needed to explore the therapeutic potential of these natural compounds.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Mycology

Background:

  • Beta-secretase 1 (BACE1) is a key enzyme in Alzheimer's disease pathogenesis, with elevated levels observed in affected brains.
  • Fungal endophytes, microorganisms residing within plant tissues, are a potential source of novel bioactive compounds.

Purpose of the Study:

  • To investigate the BACE1 inhibitory activity of fungal endophytic extracts.
  • To assess the cytotoxicity of these extracts against neuronal and hepatic cell lines.

Main Methods:

  • Endophytes were isolated from plants and their extracts were screened for BACE1 inhibition.
  • Cytotoxicity was evaluated using PC-12 and WRL68 cell lines.
  • The most active extract was further analyzed for its inhibition kinetics.

Main Results:

  • Out of 212 extracts, 29 showed over 90% BACE1 inhibition.
  • Four extracts from Cytospora rhizophorae isolates exhibited potent BACE1 inhibition (IC50 < 3.0 μg/ml).
  • The most active extract, HAB16R13, non-competitively inhibited BACE1 (Ki = 10.0 μg/ml) and displayed low cytotoxicity.

Conclusions:

  • Endophytic fungal extracts, particularly from Cytospora rhizophorae, demonstrate significant BACE1 inhibitory activity.
  • These findings highlight the potential of endophytes as a source for Alzheimer's disease therapeutics.
  • Further investigation is warranted to explore the full therapeutic potential of these fungal endophytes.